[Retracted] Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus

Abstract

In this paper, we propose a new method to analyze the risk factors of coronary heart disease (CHD) and their correlation with inflammatory factors in patients with type 2 diabetes mellitus (T2DM). To verify and implement this idea, we have selected a total of 165 patients with T2DM treated in our hospital from March 2019 to October 2021 that were divided into CHD group ( n = 72 ) and non-CHD group ( n = 93 ) according to the results of coronary angiography. Patients with CHD were divided into three groups according to SYNTAX score: low-risk group, medium-risk group, and high-risk group. The clinical data of all patients were collected. Univariate and multivariate analyses were used to screen the risk factors of CHD in patients with T2DM. The related inflammatory factors such as C-reactive protein (CRP), interleukin-6 (IL-6), and water-soluble CD40 ligand (sCD40L) were detected in all patients. Pearson’s linear correlation analysis was used to analyze the correlation between the expression levels of CRP, IL-6, and sCD40L and CHD in patients with T2DM. The receiver working curve (ROC) was used to evaluate the efficacy of IL-6, CRP, and sCD40L in predicting high risk of CHD in patients with T2DM. Multivariate analysis showed that age and course of T2DM, FFA, UA, and Hcy were risk factors for CHD in patients with T2DM. The serum levels of IL-6, CRP, and sCD40L in patients with CHD were significantly higher than those in patients without CHD. According to SYNTAX score, 72 patients with CHD were divided into low-risk group ( n = 36 ), medium-risk group ( n = 26 ), and high-risk group ( n = 10 ). Compared with the low-risk group, the expression levels of serum IL-6 CRP and sCD40L in the middle-risk group and high-risk group were significantly higher than those in the low-risk group. The expression levels of IL-6 CRP and sCD40L in the high-risk group were also significantly higher than those in the medium-risk group. There is a positive correlation between syntactic score and IL-6 expression in patients with T2DM complicated with coronary heart disease ( r = 0.778 , P < 0.001 ), with the expression of CRP ( r = 0.756 , P < 0.001 ) and with the expression of sCD40L ( r = 0.748 , P < 0.001 ). Advanced age, long course of T2DM, elevated levels of FFA, UA, and Hcy are all risk factors of CHD in patients with type 2 diabetes. T2DM patients with the above risk factors should be vigilant and pay attention to monitoring the related indexes of coronary heart disease to avoid the occurrence of serious cardiovascular disease. CRP, IL-6, and sCD40L are involved in the progression of CHD in patients with T2DM. The more severe CHD is, the higher the expression of IL-6, CRP, and sCD40L in serum.

Therapeutic potential of nutritional food for a healthy cardiometabolic system—a review of molecular mechanism

“…By reducing inflammation and triacylglycerol, omega-3 fatty acids can decrease the risk of heart disease and plaque buildup (Mason et al, 2020). Furthermore, insulin increases smooth muscle proliferation in coronary arteries, making them more susceptible to clots (Wang et al, 2022). Sugar consumption determines a person's heart attack risk regardless of calorie consumption or obesity.…”

Urgensi Pelaksanaan Skrining Riwayat Kesehatan Peserta JKN-KIS dengan Pendekatan Stakeholder Engagement

“…Disisi lain, kejadian hipertensi yang disertai dengan DM memiliki peranan penting terhadap terjadinya penyakit ginjal (Braunwald, 2019). Selanjutnya Penyakit jantung koroner juga meningkat pada pasien DM dan 50% mengalami komplikasi penyakit jantung koroner (Wang et al, 2022).…”

A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China

“…According to the International Diabetes Federation (IDF) report, the number of diabetes patients in China have been exceed 140 million currently [ 3 ]. Diabetes correlates with various diseases, such as thyroid dysfunction [ 4 , 5 ], lipid metabolism disorder [ 6 ], purine metabolic disorder [ 7 ], cardiovascular disease [ 8 ], and cognitive function [ 9 ]. Long-term hyperglycemia leads to islet β-cells depletion and failure, ultimately resulting in hyperglycemia and metabolic decompensation [ 10 ].…”